DCM
BSX icon

DG Capital Management’s Boston Scientific BSX Stock Holding History

DG Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-115,620
Closed -$4.16M – 127
2020
Q4 		$4.16M Buy
+115,620
New +$4.17M 1.76% 22

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

DG Capital Management's BSX Position: Q1 2021 in Review

DG Capital Management sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 115,620 shares — an estimated $4.16M sold.

DG Capital Management first reported a position in BSX in Q4 2020 and held it in 1 quarter. The position peaked at $4.16M in Q4 2020. 831 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • DG Capital Management reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • DG Capital Management sold 115,620 Boston Scientific shares in Q1 2021, an estimated $4.16M.
  • DG Capital Management first reported a position in Boston Scientific in Q4 2020 and held it in 1 quarter.
  • DG Capital Management's Boston Scientific position peaked at $4.16M in Q4 2020.
  • 831 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on DG Capital Management's 13F filing for Q1 2021, filed 13 May 2021.